Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio Growth (1y) (2015 - 2024)
Scinai Immunotherapeutics (SCNI) Interest Coverage Ratio Growth (1y) (2015 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,440.76 Bn | 66,440.47 Bn | - | -60.44% |
| 2 | Nanobiotix | 1,880.51 Bn | 1,880.45 Bn | - | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - | -347.04% |
| 4 | BeOne Medicines | 467.94 Bn | 463.15 Bn | 1.35 Bn | 787.12% |
| 5 | Vertex Pharmaceuticals | 122.63 Bn | 115.38 Bn | 2.59 Bn | 53.59% |
| 6 | Regeneron Pharmaceuticals | 70.30 Bn | 61.54 Bn | 3.31 Bn | -32.04% |
| 7 | Belite Bio | 62.81 Bn | 62.81 Bn | - | - |
| 8 | Argenx Se | 55.78 Bn | 50.59 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.33 Bn | 34.32 Bn | 959.66 Mn | 1,378.45% |
| 10 | Scinai Immunotherapeutics | 3.62 Bn | 508.97 Mn | -1.12 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 90.24% |
| Mar 31, 2024 | 206.81% |
| Dec 31, 2023 | -204.89% |
| Mar 31, 2023 | 23.85% |
| Dec 31, 2022 | -120.83% |
| Sep 30, 2022 | -71.20% |
| Jun 30, 2022 | -131.11% |
| Mar 31, 2022 | 37.30% |
| Dec 31, 2021 | 27.71% |
| Sep 30, 2021 | 101.52% |
| Mar 31, 2021 | -98.09% |
| Sep 30, 2020 | -713.18% |
| Mar 31, 2020 | 3,724.82% |
| Sep 30, 2019 | 762.11% |
| Jun 30, 2019 | -99.66% |
| Mar 31, 2019 | -55.84% |
| Dec 31, 2018 | -1,095.89% |
| Mar 31, 2018 | 2,298.17% |
| Mar 31, 2017 | -95.03% |
| Mar 31, 2016 | -82.66% |